AUS
NZ
UK
CA
USA
IND
Health
Radiopharm Theranostics Draws Attention After Insider Buying
May 17, 2026 10:46 AM AEST| By SamRadiopharm Theranostics continues attracting market attention as insider buying activity and growing interest in precision oncology shape sentiment around the emerging healthcare company.
Why Cochlear Is Quietly Regaining Market Attention
May 17, 2026 10:43 AM AEST| By SamCochlear continues attracting investor attention as healthcare stocks regain momentum through defensive demand trends, ageing population exposure, and long-term medical technology growth themes.
Why ResMed Shares Are Back in Focus Amid Healthcare Technology Shifts
May 16, 2026 01:15 PM AEST| By SamResMed and QBE are drawing renewed attention as healthcare technology adoption, ageing populations, and financial resilience continue shaping long-term ASX market trends.
Healthy Chef Expands Nationwide With Priceline Partnership
May 15, 2026 03:54 PM AEST| By SamElixinol Wellness expands The Healthy Chef into Priceline stores across Australia, boosting wellness retail exposure and strengthening its position in the growing nutrition market.
ASX Healthcare Sector Faces Renewed Market Pressure
May 15, 2026 03:50 PM AEST| By SamASX healthcare shares witnessed heightened volatility as major companies revised earnings outlooks, while innovative medical technology firms continued expanding commercial opportunities in global healthcare markets.
ASX Healthcare Share Pushes Ahead With RC220 Trial
May 15, 2026 03:17 PM AEST| By SamRacura Oncology advanced its RC220 clinical trial after receiving approval for higher dosage levels, highlighting growing momentum across Australia’s biotechnology and oncology research sector.
Pacific Edge Expands Funding Base as Healthcare Competition Intensifies
May 15, 2026 02:56 PM AEST| By SamPacific Edge expanded its capital base as diagnostics innovation and healthcare technology transformation continued reshaping medical testing markets.
Why Anteris Technologies Is Drawing Attention Despite Cash Burn Concerns
May 15, 2026 02:48 PM AEST| By SamAnteris Technologies remained in focus as strong liquidity and healthcare innovation themes supported attention toward its cardiovascular technology development strategy.
Telix Pharma Expands Imaging Focus Across Cancer Care
May 15, 2026 02:46 PM AEST| By SamTelix Pharmaceuticals expands its cancer imaging portfolio with kidney and brain diagnostic advancements, strengthening its healthcare market presence and drawing attention across the biotechnology sector.
Why Anteris Technologies Is Drawing Attention Despite Cash Burn
May 15, 2026 11:03 AM AEST| By SamAnteris Technologies remained in focus as investors weighed its cash runway, cardiovascular innovation strategy, and long-term positioning within the evolving global medtech sector.
ASX 200 Biotech Sector Watch Amid Healthcare Market Activity
May 15, 2026 10:33 AM AEST| By SamAustralian biotechnology stocks remained under market attention as healthcare innovation, medical research participation, and clinical development activity continued shaping broader healthcare sector operations.
Why ASX Functional Beverage Stocks Are Gaining Momentum
May 15, 2026 10:24 AM AEST| By SamASX-listed beverage companies are capitalising on rising demand for wellness drinks, hydration products, protein beverages, and alcohol alternatives as health-conscious consumer behaviour reshapes the global drinks industry.
Osteopore Malaysia Approval Gains ASX 300 Focus
May 15, 2026 09:57 AM AEST| By SamOsteopore strengthened healthcare technology visibility following orthopaedic approval developments linked to regional healthcare expansion activity in Malaysia.
Why This ASX Biotech Name Is Drawing Fresh Market Attention
May 15, 2026 09:35 AM AEST| By SamImugene attracted renewed market attention as investors focused on oncology innovation, advanced cell therapy development, and the broader transformation underway across global healthcare and precision medicine infrastructure.
Tax-Free Edge Driving Attention Towards Acrux Shares
May 14, 2026 05:54 PM AEST| By SamAcrux shareholders remain shielded from Australia’s latest capital gains tax overhaul, strengthening attention on tax-efficient investment structures and the evolving landscape of Australian equities.
Breathes New Life Into Anxiety Care With Clinical Progress
May 14, 2026 03:50 PM AEST| By SamNexalis Therapeutics advances inhaled CBD research after completing an important clinical study milestone, highlighting innovation in mental health treatment and biotechnology development.
Why CSL’s Recovery Story Is Turning Heads on the ASX Stocks
May 14, 2026 03:23 PM AEST| By SamCSL is showing signs of operational recovery as plasma collections improve, vaccine demand remains resilient, and healthcare trends continue supporting long-term growth across specialised global markets.
ASX 200 Healthcare Stock Watch: TLX In Focus
May 14, 2026 12:53 PM AEST| By SamASX biotechnology and healthcare sector remained in focus as TLX continued attracting attention through radiopharmaceutical activity and healthcare innovation developments.
ASX 20 Healthcare Sector Update: CSL Shares And Market Activity
May 14, 2026 10:59 AM AEST| By SamAustralia’s healthcare sector remained active as CSL continued drawing attention through biotechnology operations, plasma services, and pharmaceutical market participation.
Why These ASX Healthcare Shares Are Riding Australia’s Ageing Boom
May 14, 2026 10:31 AM AEST| By SamAustralia’s ageing population continued driving attention toward healthcare and aged care companies as demand for residential care, rehabilitation and hospital services strengthened across the sector.
Advertise your brand on Kalkine Media